Stephen W. Potter

Senior Vice President, Osiris Therapeutics.

Companies

Applied Genetic Technologies CorporationVP and Chief Business Officer Feb 2, 2015 to Dec 1, 2022¹
Caladrius BiosciencesExecutive Vice President Jul 17, 2013 to Jan 2, 2015²
Caladrius BiosciencesBoard member Feb 12, 2013 to Feb 12, 2013³
Osiris TherapeuticsSenior Vice President Feb 8, 2011 to Mar 27, 2012⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Applied Genetic Technologies Corporation AGTC0 shares⁵Nov 30, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 30, 2022Returned to company 8,750 shares of Applied Genetic Technologies Corporation⁵
Nov 30, 2022U 47,133 shares of Applied Genetic Technologies Corporation⁵
Jul 1, 2022Sold 8,070 shares at $0.77 of Applied Genetic Technologies Corporation⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARApplied Genetic Technologies Corporation, VP and Chief Business Officer
2
SEC EDGARCaladrius Biosciences, Executive Vice President
3
SEC EDGARCaladrius Biosciences, Board member
4
SEC EDGAROsiris Therapeutics, Senior Vice President
5
SEC EDGARApplied Genetic Technologies Corporation shares after the filing of Nov 30, 2022
6
SEC EDGARForm 4 filed Jul 1, 2022